

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.48387201 |
| 2 | establishment of apical/basal cell polarity (GO:0035089) | 5.32521857 |
| 3 | proline biosynthetic process (GO:0006561) | 5.13987557 |
| 4 | regulation of vitamin metabolic process (GO:0030656) | 4.94886122 |
| 5 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.79168522 |
| 6 | establishment of monopolar cell polarity (GO:0061162) | 4.79168522 |
| 7 | response to peptidoglycan (GO:0032494) | 4.48537769 |
| 8 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.36074694 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.35264150 |
| 10 | embryonic process involved in female pregnancy (GO:0060136) | 4.33990799 |
| 11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.24030715 |
| 12 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.21998062 |
| 13 | regulation of fever generation (GO:0031620) | 4.16879891 |
| 14 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.16595226 |
| 15 | positive regulation of heat generation (GO:0031652) | 4.15423980 |
| 16 | regulation of mononuclear cell migration (GO:0071675) | 4.09645904 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 3.90003153 |
| 18 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.88418845 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.82214734 |
| 20 | cell migration in hindbrain (GO:0021535) | 3.81030534 |
| 21 | glycosphingolipid catabolic process (GO:0046479) | 3.78291787 |
| 22 | T-helper 1 type immune response (GO:0042088) | 3.74201416 |
| 23 | regulation of hippo signaling (GO:0035330) | 3.69633795 |
| 24 | locomotory exploration behavior (GO:0035641) | 3.67154274 |
| 25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.66794898 |
| 26 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.64667962 |
| 27 | regulation of chemokine biosynthetic process (GO:0045073) | 3.59952110 |
| 28 | polarized epithelial cell differentiation (GO:0030859) | 3.58035275 |
| 29 | activation of Rac GTPase activity (GO:0032863) | 3.56619103 |
| 30 | protein localization to endosome (GO:0036010) | 3.46229180 |
| 31 | oligosaccharide catabolic process (GO:0009313) | 3.44028980 |
| 32 | positive regulation of protein homooligomerization (GO:0032464) | 3.42909876 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.42318330 |
| 34 | neuromuscular process controlling balance (GO:0050885) | 3.41785243 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.41217472 |
| 36 | glycolipid catabolic process (GO:0019377) | 3.40840878 |
| 37 | myeloid dendritic cell differentiation (GO:0043011) | 3.39144762 |
| 38 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.37258403 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.35947058 |
| 40 | negative regulation of Ras GTPase activity (GO:0034261) | 3.32865666 |
| 41 | proline metabolic process (GO:0006560) | 3.32780559 |
| 42 | regulation of chronic inflammatory response (GO:0002676) | 3.29186434 |
| 43 | synaptic vesicle endocytosis (GO:0048488) | 3.27190995 |
| 44 | glial cell migration (GO:0008347) | 3.27164058 |
| 45 | activation of MAPKKK activity (GO:0000185) | 3.24812536 |
| 46 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.24624706 |
| 47 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.22102632 |
| 48 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.19176899 |
| 49 | regulation of cholesterol storage (GO:0010885) | 3.18377438 |
| 50 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.16450286 |
| 51 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.16005484 |
| 52 | low-density lipoprotein particle clearance (GO:0034383) | 3.12925443 |
| 53 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 3.12847457 |
| 54 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 3.12847457 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 3.12711574 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.12711574 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12711574 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.12711574 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 3.12711574 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12711574 |
| 61 | monocyte chemotaxis (GO:0002548) | 3.09060389 |
| 62 | vocalization behavior (GO:0071625) | 3.08946414 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 3.08478837 |
| 64 | virion attachment to host cell (GO:0019062) | 3.08478837 |
| 65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07583890 |
| 66 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.06174743 |
| 67 | germinal center formation (GO:0002467) | 3.05963463 |
| 68 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.05009021 |
| 69 | cellular response to ATP (GO:0071318) | 3.04791247 |
| 70 | adhesion of symbiont to host (GO:0044406) | 3.02935314 |
| 71 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.02560794 |
| 72 | negative regulation of catenin import into nucleus (GO:0035414) | 3.00934355 |
| 73 | regulation of heat generation (GO:0031650) | 2.98574509 |
| 74 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.98360339 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.98259131 |
| 76 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.96637307 |
| 77 | anterior/posterior axis specification, embryo (GO:0008595) | 2.96313959 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.95796270 |
| 79 | sodium ion export (GO:0071436) | 2.95713835 |
| 80 | regulation of macrophage chemotaxis (GO:0010758) | 2.94926991 |
| 81 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94516835 |
| 82 | positive regulation of type 2 immune response (GO:0002830) | 2.94216397 |
| 83 | embryonic camera-type eye development (GO:0031076) | 2.93125299 |
| 84 | cellular response to lipopolysaccharide (GO:0071222) | 2.90636475 |
| 85 | nodal signaling pathway (GO:0038092) | 2.90518230 |
| 86 | convergent extension (GO:0060026) | 2.90380641 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 2.89319590 |
| 88 | cellular response to type I interferon (GO:0071357) | 2.89139623 |
| 89 | type I interferon signaling pathway (GO:0060337) | 2.89139623 |
| 90 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.88976301 |
| 91 | transcription from mitochondrial promoter (GO:0006390) | 2.87537164 |
| 92 | positive regulation of synapse maturation (GO:0090129) | 2.87298375 |
| 93 | apoptotic process involved in morphogenesis (GO:0060561) | 2.86503908 |
| 94 | dendritic spine morphogenesis (GO:0060997) | 2.86416186 |
| 95 | response to type I interferon (GO:0034340) | 2.86355777 |
| 96 | ceramide catabolic process (GO:0046514) | 2.86299925 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.86042419 |
| 98 | regulation of glomerular filtration (GO:0003093) | 2.85617146 |
| 99 | membrane lipid catabolic process (GO:0046466) | 2.84336440 |
| 100 | modulation by symbiont of host cellular process (GO:0044068) | 2.84259446 |
| 101 | glial cell proliferation (GO:0014009) | 2.83303902 |
| 102 | embryonic placenta development (GO:0001892) | 2.82896049 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81682278 |
| 104 | regulation of translational fidelity (GO:0006450) | 2.81600357 |
| 105 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80544567 |
| 106 | hypotonic response (GO:0006971) | 2.78777148 |
| 107 | cellular response to molecule of bacterial origin (GO:0071219) | 2.78573391 |
| 108 | synaptic vesicle exocytosis (GO:0016079) | 2.75887730 |
| 109 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.75713602 |
| 110 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75444378 |
| 111 | adherens junction assembly (GO:0034333) | 2.75366525 |
| 112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74782090 |
| 113 | establishment of nucleus localization (GO:0040023) | 2.74368574 |
| 114 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.74272345 |
| 115 | N-glycan processing (GO:0006491) | 2.74001067 |
| 116 | anatomical structure regression (GO:0060033) | 2.73052743 |
| 117 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.72441984 |
| 118 | G1 DNA damage checkpoint (GO:0044783) | 2.72350521 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 2.72252283 |
| 120 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71436243 |
| 121 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70671142 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.70005467 |
| 123 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.69916487 |
| 124 | glutamate secretion (GO:0014047) | 2.69654429 |
| 125 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.69403012 |
| 126 | mitotic G1/S transition checkpoint (GO:0044819) | 2.67982119 |
| 127 | sphingolipid catabolic process (GO:0030149) | 2.66729164 |
| 128 | dendritic cell differentiation (GO:0097028) | 2.66517066 |
| 129 | collecting duct development (GO:0072044) | 2.65657153 |
| 130 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63572857 |
| 131 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.62037624 |
| 132 | neutrophil activation involved in immune response (GO:0002283) | 2.62006770 |
| 133 | regulation of ARF GTPase activity (GO:0032312) | 2.61602174 |
| 134 | response to protozoan (GO:0001562) | 2.61544798 |
| 135 | protein heterotrimerization (GO:0070208) | 2.58293782 |
| 136 | proline transport (GO:0015824) | 2.58202140 |
| 137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57017521 |
| 138 | negative regulation of cartilage development (GO:0061037) | 2.56582399 |
| 139 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56474044 |
| 140 | angiotensin maturation (GO:0002003) | 2.56335666 |
| 141 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.56240242 |
| 142 | labyrinthine layer development (GO:0060711) | 2.56117412 |
| 143 | trophectodermal cell differentiation (GO:0001829) | 2.55224985 |
| 144 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.55127701 |
| 145 | cell-cell junction maintenance (GO:0045217) | 2.54680387 |
| 146 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.54572358 |
| 147 | barbed-end actin filament capping (GO:0051016) | 2.54205715 |
| 148 | positive regulation of interleukin-6 production (GO:0032755) | 2.53818336 |
| 149 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.53014280 |
| 150 | positive regulation of extracellular matrix organization (GO:1903055) | 2.51807786 |
| 151 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.51337425 |
| 152 | * regulation of podosome assembly (GO:0071801) | 2.51122309 |
| 153 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50350287 |
| 154 | hippo signaling (GO:0035329) | 2.49842603 |
| 155 | pinocytosis (GO:0006907) | 2.49694604 |
| 156 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.49088608 |
| 157 | exploration behavior (GO:0035640) | 2.48913901 |
| 158 | decidualization (GO:0046697) | 2.47988108 |
| 159 | pre-miRNA processing (GO:0031054) | 2.47021703 |
| 160 | protein targeting to lysosome (GO:0006622) | 2.46977781 |
| 161 | establishment of protein localization to vacuole (GO:0072666) | 2.46977781 |
| 162 | protein targeting to vacuole (GO:0006623) | 2.46977781 |
| 163 | detection of molecule of bacterial origin (GO:0032490) | 2.46936194 |
| 164 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46023640 |
| 165 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.45942821 |
| 166 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.45785380 |
| 167 | regulation of gene silencing by miRNA (GO:0060964) | 2.45785380 |
| 168 | regulation of gene silencing by RNA (GO:0060966) | 2.45785380 |
| 169 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.45761218 |
| 170 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45665751 |
| 171 | regulation of interleukin-12 production (GO:0032655) | 2.45173947 |
| 172 | dendrite morphogenesis (GO:0048813) | 2.45138814 |
| 173 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.44659072 |
| 174 | neuromuscular process controlling posture (GO:0050884) | 2.44498342 |
| 175 | negative regulation of glial cell proliferation (GO:0060253) | 2.44253383 |
| 176 | negative regulation of lipid storage (GO:0010888) | 2.44101405 |
| 177 | defense response to protozoan (GO:0042832) | 2.44053815 |
| 178 | positive regulation of interferon-alpha production (GO:0032727) | 2.43762018 |
| 179 | neuromuscular process (GO:0050905) | 2.43212902 |
| 180 | spinal cord development (GO:0021510) | 2.42954864 |
| 181 | protein retention in ER lumen (GO:0006621) | 2.41935896 |
| 182 | cyclooxygenase pathway (GO:0019371) | 2.41915675 |
| 183 | cellular response to biotic stimulus (GO:0071216) | 2.41809979 |
| 184 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41673852 |
| 185 | renal system process involved in regulation of blood volume (GO:0001977) | 2.40771752 |
| 186 | response to thyroid hormone (GO:0097066) | 2.40291884 |
| 187 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.40265173 |
| 188 | regulation of type 2 immune response (GO:0002828) | 2.39313344 |
| 189 | cellular potassium ion homeostasis (GO:0030007) | 2.38434867 |
| 190 | asymmetric protein localization (GO:0008105) | 2.38221648 |
| 191 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.37728583 |
| 192 | histone H4-K12 acetylation (GO:0043983) | 2.36474590 |
| 193 | neural tube closure (GO:0001843) | 2.36285796 |
| 194 | negative regulation of GTPase activity (GO:0034260) | 2.35626589 |
| 195 | negative regulation of GTP catabolic process (GO:0033125) | 2.35626589 |
| 196 | dendritic spine organization (GO:0097061) | 2.35330568 |
| 197 | plasma membrane repair (GO:0001778) | 2.34655295 |
| 198 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.33913060 |
| 199 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.31753964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.38428742 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.35014764 |
| 3 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.22959264 |
| 4 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 3.21241444 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.12883645 |
| 6 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.96252247 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.88504493 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88437925 |
| 9 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.69281362 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64021361 |
| 11 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.59858495 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49745050 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37827648 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37518720 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31858688 |
| 16 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.28226367 |
| 17 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.15044792 |
| 18 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.13681234 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.13290833 |
| 20 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.12010838 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.11060007 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.11060007 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.11060007 |
| 24 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08572537 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08311108 |
| 26 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.07741277 |
| 27 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.07134732 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06280658 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03635118 |
| 30 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.01115662 |
| 31 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.92511468 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91186934 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85771535 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82518852 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79127283 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78804088 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.78742677 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76521679 |
| 39 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.76413189 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72607319 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71076324 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69369254 |
| 43 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.68368584 |
| 44 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.68088954 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.67009895 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66845881 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65064980 |
| 48 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.64292097 |
| 49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61740079 |
| 50 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.60712883 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60316140 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59888730 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59882553 |
| 54 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.58632013 |
| 55 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.57109243 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56392782 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.55306595 |
| 58 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.54931226 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53943128 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51622885 |
| 61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.47628732 |
| 62 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46775059 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46517168 |
| 64 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45751165 |
| 65 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.41244866 |
| 66 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41059349 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40042758 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39388375 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39376877 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39375392 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39251797 |
| 72 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.38819393 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38650199 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38423756 |
| 75 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37919722 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37829844 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36922317 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36612729 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35385720 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35112482 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34834490 |
| 82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33871123 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33871123 |
| 84 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.33551161 |
| 85 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32402636 |
| 86 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32332264 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30957188 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29517081 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29339010 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29120704 |
| 91 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.29001093 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28837434 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28298706 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27809501 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25097584 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24566267 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24382822 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23937701 |
| 99 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22072593 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21860630 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19956924 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19240175 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19197874 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19056271 |
| 105 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.18596561 |
| 106 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18378160 |
| 107 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.17848002 |
| 108 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17157467 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 1.17051436 |
| 110 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16906687 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16605075 |
| 112 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16335065 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15980242 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15054795 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14987685 |
| 116 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14495966 |
| 117 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13972530 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13333880 |
| 119 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12620971 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12480170 |
| 121 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11537230 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11505267 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11445587 |
| 124 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10469589 |
| 125 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.10065486 |
| 126 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09886748 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09616361 |
| 128 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09429399 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09091072 |
| 130 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08909793 |
| 131 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.08428171 |
| 132 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06398378 |
| 133 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06367522 |
| 134 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04936139 |
| 135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04868000 |
| 136 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04704874 |
| 137 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03927759 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03648002 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03150762 |
| 140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03020346 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02663821 |
| 142 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02519068 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02457048 |
| 144 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01708793 |
| 145 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01703176 |
| 146 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01078081 |
| 147 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99992005 |
| 148 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99727459 |
| 149 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99100868 |
| 150 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.98865892 |
| 151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97486260 |
| 152 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97056865 |
| 153 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96856463 |
| 154 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.96719196 |
| 155 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.96218306 |
| 156 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96040846 |
| 157 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95953754 |
| 158 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.95912984 |
| 159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95800289 |
| 160 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95315183 |
| 161 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95197247 |
| 162 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.95042310 |
| 163 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93885173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.22953514 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.49825657 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.87135087 |
| 4 | MP0003283_abnormal_digestive_organ | 3.67849848 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.51312623 |
| 6 | MP0009840_abnormal_foam_cell | 3.29355849 |
| 7 | MP0003436_decreased_susceptibility_to | 3.23644737 |
| 8 | MP0004510_myositis | 3.13745897 |
| 9 | MP0004858_abnormal_nervous_system | 3.05362553 |
| 10 | MP0010030_abnormal_orbit_morphology | 3.03080632 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.88549569 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.83945966 |
| 13 | MP0006082_CNS_inflammation | 2.76750844 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.71483647 |
| 15 | MP0009785_altered_susceptibility_to | 2.71259766 |
| 16 | MP0005451_abnormal_body_composition | 2.63330805 |
| 17 | MP0005171_absent_coat_pigmentation | 2.61031409 |
| 18 | MP0005623_abnormal_meninges_morphology | 2.55601610 |
| 19 | MP0004233_abnormal_muscle_weight | 2.52206153 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.51663438 |
| 21 | MP0009278_abnormal_bone_marrow | 2.49218373 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.36112858 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.33914557 |
| 24 | MP0005076_abnormal_cell_differentiation | 2.29951618 |
| 25 | MP0003724_increased_susceptibility_to | 2.19697626 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.13756402 |
| 27 | MP0003119_abnormal_digestive_system | 2.13655824 |
| 28 | MP0004947_skin_inflammation | 2.12526263 |
| 29 | MP0005387_immune_system_phenotype | 2.12100997 |
| 30 | MP0001790_abnormal_immune_system | 2.12100997 |
| 31 | MP0002419_abnormal_innate_immunity | 2.11589733 |
| 32 | MP0005025_abnormal_response_to | 2.01254500 |
| 33 | MP0000604_amyloidosis | 1.98371810 |
| 34 | MP0009764_decreased_sensitivity_to | 1.98202525 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.98056442 |
| 36 | MP0000343_altered_response_to | 1.97439329 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.94643241 |
| 38 | MP0000537_abnormal_urethra_morphology | 1.93758675 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.92044242 |
| 40 | MP0008004_abnormal_stomach_pH | 1.88246735 |
| 41 | MP0005671_abnormal_response_to | 1.83231252 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.81793516 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.76325503 |
| 44 | MP0000858_altered_metastatic_potential | 1.71563694 |
| 45 | MP0001849_ear_inflammation | 1.71522016 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.70162444 |
| 47 | * MP0002998_abnormal_bone_remodeling | 1.69439205 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.68893595 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.65933806 |
| 50 | MP0006054_spinal_hemorrhage | 1.65029727 |
| 51 | MP0004270_analgesia | 1.61742333 |
| 52 | MP0000685_abnormal_immune_system | 1.61500617 |
| 53 | MP0003890_abnormal_embryonic-extraembry | 1.57840859 |
| 54 | MP0003045_fibrosis | 1.57439638 |
| 55 | MP0002723_abnormal_immune_serum | 1.56539748 |
| 56 | MP0004133_heterotaxia | 1.55652128 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.53261668 |
| 58 | MP0000778_abnormal_nervous_system | 1.52051930 |
| 59 | MP0000462_abnormal_digestive_system | 1.52019664 |
| 60 | MP0003448_altered_tumor_morphology | 1.50029295 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.47615977 |
| 62 | * MP0001845_abnormal_inflammatory_respons | 1.44944275 |
| 63 | MP0001800_abnormal_humoral_immune | 1.43444045 |
| 64 | MP0005166_decreased_susceptibility_to | 1.42686057 |
| 65 | MP0003385_abnormal_body_wall | 1.41809678 |
| 66 | MP0008469_abnormal_protein_level | 1.39671375 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.39441610 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.37752829 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.35365634 |
| 70 | MP0001853_heart_inflammation | 1.35074377 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.34747945 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.34532075 |
| 73 | MP0003091_abnormal_cell_migration | 1.32380283 |
| 74 | MP0005310_abnormal_salivary_gland | 1.31838691 |
| 75 | MP0002282_abnormal_trachea_morphology | 1.31056578 |
| 76 | MP0004811_abnormal_neuron_physiology | 1.30768790 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 1.30737579 |
| 78 | MP0003075_altered_response_to | 1.28173080 |
| 79 | MP0000955_abnormal_spinal_cord | 1.28046710 |
| 80 | MP0009053_abnormal_anal_canal | 1.26947716 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 1.26549923 |
| 82 | MP0002064_seizures | 1.24809800 |
| 83 | MP0008260_abnormal_autophagy | 1.24785176 |
| 84 | MP0002249_abnormal_larynx_morphology | 1.24638151 |
| 85 | MP0003690_abnormal_glial_cell | 1.24634197 |
| 86 | MP0002084_abnormal_developmental_patter | 1.24516387 |
| 87 | MP0002733_abnormal_thermal_nociception | 1.23855948 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 1.23738562 |
| 89 | MP0000516_abnormal_urinary_system | 1.23738562 |
| 90 | MP0001819_abnormal_immune_cell | 1.22133192 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.19963018 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.19592229 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 1.17711248 |
| 94 | MP0001545_abnormal_hematopoietic_system | 1.17711248 |
| 95 | MP0002405_respiratory_system_inflammati | 1.17458019 |
| 96 | MP0000467_abnormal_esophagus_morphology | 1.16984155 |
| 97 | MP0003755_abnormal_palate_morphology | 1.15361092 |
| 98 | MP0009046_muscle_twitch | 1.15134879 |
| 99 | MP0004885_abnormal_endolymph | 1.13868418 |
| 100 | MP0002796_impaired_skin_barrier | 1.13822046 |
| 101 | MP0005248_abnormal_Harderian_gland | 1.12762434 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 1.08957469 |
| 103 | MP0003861_abnormal_nervous_system | 1.08413323 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 1.08005178 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 1.07585373 |
| 106 | MP0003115_abnormal_respiratory_system | 1.05872223 |
| 107 | MP0005164_abnormal_response_to | 1.01824808 |
| 108 | MP0003942_abnormal_urinary_system | 1.01464138 |
| 109 | MP0002085_abnormal_embryonic_tissue | 1.01271716 |
| 110 | * MP0002086_abnormal_extraembryonic_tissu | 0.98551052 |
| 111 | MP0009745_abnormal_behavioral_response | 0.97784001 |
| 112 | MP0000733_abnormal_muscle_development | 0.95846091 |
| 113 | MP0003941_abnormal_skin_development | 0.95624807 |
| 114 | MP0005390_skeleton_phenotype | 0.94500501 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.94405448 |
| 116 | MP0002152_abnormal_brain_morphology | 0.94132244 |
| 117 | MP0000920_abnormal_myelination | 0.93626025 |
| 118 | MP0000579_abnormal_nail_morphology | 0.93288895 |
| 119 | MP0001970_abnormal_pain_threshold | 0.93248507 |
| 120 | MP0004272_abnormal_basement_membrane | 0.93111219 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.92954453 |
| 122 | MP0003935_abnormal_craniofacial_develop | 0.92842467 |
| 123 | MP0001293_anophthalmia | 0.92710997 |
| 124 | MP0002932_abnormal_joint_morphology | 0.91715063 |
| 125 | MP0005365_abnormal_bile_salt | 0.90647334 |
| 126 | MP0003329_amyloid_beta_deposits | 0.89362894 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.88341745 |
| 128 | MP0002111_abnormal_tail_morphology | 0.87928123 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.87619668 |
| 130 | MP0002254_reproductive_system_inflammat | 0.87237491 |
| 131 | MP0002877_abnormal_melanocyte_morpholog | 0.87054324 |
| 132 | MP0003880_abnormal_central_pattern | 0.86557267 |
| 133 | MP0001663_abnormal_digestive_system | 0.86132852 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.85886687 |
| 135 | MP0002184_abnormal_innervation | 0.85615603 |
| 136 | * MP0002116_abnormal_craniofacial_bone | 0.85143728 |
| 137 | MP0001216_abnormal_epidermal_layer | 0.84632921 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.83562831 |
| 139 | MP0005023_abnormal_wound_healing | 0.83144354 |
| 140 | MP0000716_abnormal_immune_system | 0.81904244 |
| 141 | MP0008438_abnormal_cutaneous_collagen | 0.80085102 |
| 142 | MP0005165_increased_susceptibility_to | 0.79961796 |
| 143 | MP0005508_abnormal_skeleton_morphology | 0.79730377 |
| 144 | MP0002909_abnormal_adrenal_gland | 0.79632966 |
| 145 | MP0003634_abnormal_glial_cell | 0.79487685 |
| 146 | MP0003795_abnormal_bone_structure | 0.78007446 |
| 147 | MP0002138_abnormal_hepatobiliary_system | 0.77844158 |
| 148 | MP0005645_abnormal_hypothalamus_physiol | 0.77093878 |
| 149 | MP0008057_abnormal_DNA_replication | 0.75938708 |
| 150 | MP0005360_urolithiasis | 0.75387894 |
| 151 | MP0000249_abnormal_blood_vessel | 0.74829909 |
| 152 | MP0002896_abnormal_bone_mineralization | 0.74325741 |
| 153 | MP0009763_increased_sensitivity_to | 0.74318525 |
| 154 | MP0001697_abnormal_embryo_size | 0.73682000 |
| 155 | MP0008961_abnormal_basal_metabolism | 0.73033235 |
| 156 | * MP0000432_abnormal_head_morphology | 0.72715245 |
| 157 | MP0008874_decreased_physiological_sensi | 0.72498364 |
| 158 | MP0000751_myopathy | 0.72287020 |
| 159 | MP0006072_abnormal_retinal_apoptosis | 0.71028520 |
| 160 | MP0003122_maternal_imprinting | 0.71010131 |
| 161 | MP0000470_abnormal_stomach_morphology | 0.70590045 |
| 162 | MP0002697_abnormal_eye_size | 0.69595094 |
| 163 | MP0001440_abnormal_grooming_behavior | 0.68281999 |
| 164 | MP0003806_abnormal_nucleotide_metabolis | 0.68149008 |
| 165 | MP0008770_decreased_survivor_rate | 0.67554160 |
| 166 | MP0002114_abnormal_axial_skeleton | 0.67497724 |
| 167 | MP0002734_abnormal_mechanical_nocicepti | 0.67325830 |
| 168 | * MP0001340_abnormal_eyelid_morphology | 0.66975894 |
| 169 | MP0003195_calcinosis | 0.65948533 |
| 170 | MP0000609_abnormal_liver_physiology | 0.65718389 |
| 171 | MP0005666_abnormal_adipose_tissue | 0.64691393 |
| 172 | MP0009765_abnormal_xenobiotic_induced | 0.64610047 |
| 173 | MP0005381_digestive/alimentary_phenotyp | 0.64398001 |
| 174 | MP0000767_abnormal_smooth_muscle | 0.64349716 |
| 175 | MP0000490_abnormal_crypts_of | 0.63282032 |
| 176 | MP0002933_joint_inflammation | 0.63007729 |
| 177 | MP0002429_abnormal_blood_cell | 0.61995600 |
| 178 | MP0003279_aneurysm | 0.61435106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.79311372 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.79311372 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.79311372 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.51346206 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.22714107 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.15485686 |
| 7 | Annular pancreas (HP:0001734) | 4.01063748 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.99624125 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.91940025 |
| 10 | Turricephaly (HP:0000262) | 3.90946429 |
| 11 | Loss of speech (HP:0002371) | 3.87621608 |
| 12 | Disinhibition (HP:0000734) | 3.61430176 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.50342245 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.31030378 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26913186 |
| 16 | Nuclear cataract (HP:0100018) | 3.24042759 |
| 17 | Ulnar bowing (HP:0003031) | 3.20996755 |
| 18 | Glomerulonephritis (HP:0000099) | 3.11772297 |
| 19 | Orchitis (HP:0100796) | 3.06961769 |
| 20 | Coronal craniosynostosis (HP:0004440) | 3.06833729 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 3.06189569 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.02367057 |
| 23 | Axonal loss (HP:0003447) | 2.99356787 |
| 24 | Abnormality of the lower motor neuron (HP:0002366) | 2.98682431 |
| 25 | Myokymia (HP:0002411) | 2.96626679 |
| 26 | Mutism (HP:0002300) | 2.92558604 |
| 27 | Rib fusion (HP:0000902) | 2.90396091 |
| 28 | Alopecia of scalp (HP:0002293) | 2.90322076 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.81023253 |
| 30 | Optic neuritis (HP:0100653) | 2.81023253 |
| 31 | Apathy (HP:0000741) | 2.79777522 |
| 32 | Purpura (HP:0000979) | 2.75102922 |
| 33 | Thin bony cortex (HP:0002753) | 2.73663984 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.70702650 |
| 35 | Myocardial infarction (HP:0001658) | 2.70315077 |
| 36 | Diminished motivation (HP:0000745) | 2.67922986 |
| 37 | Short humerus (HP:0005792) | 2.64714735 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62933065 |
| 39 | Recurrent abscess formation (HP:0002722) | 2.62729647 |
| 40 | Concave nail (HP:0001598) | 2.60950617 |
| 41 | Shallow orbits (HP:0000586) | 2.60517030 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.56909857 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.56507356 |
| 44 | Malnutrition (HP:0004395) | 2.54935063 |
| 45 | Complement deficiency (HP:0004431) | 2.51808889 |
| 46 | Amyloidosis (HP:0011034) | 2.51649327 |
| 47 | Hypercortisolism (HP:0001578) | 2.44981714 |
| 48 | Myositis (HP:0100614) | 2.43980666 |
| 49 | Congenital hip dislocation (HP:0001374) | 2.43178935 |
| 50 | Vertebral hypoplasia (HP:0008417) | 2.42148362 |
| 51 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.42148362 |
| 52 | Metaphyseal irregularity (HP:0003025) | 2.41422122 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.39932363 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38831559 |
| 55 | Male infertility (HP:0003251) | 2.38524174 |
| 56 | Abnormality of the aortic arch (HP:0012303) | 2.36951254 |
| 57 | Increased serum ferritin (HP:0003281) | 2.36444706 |
| 58 | Facial hemangioma (HP:0000329) | 2.34203147 |
| 59 | Abnormality of the astrocytes (HP:0100707) | 2.33909069 |
| 60 | Astrocytoma (HP:0009592) | 2.33909069 |
| 61 | Abnormality of complement system (HP:0005339) | 2.33611515 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.33498474 |
| 63 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.31058685 |
| 64 | Ankyloglossia (HP:0010296) | 2.29516237 |
| 65 | Bowed forearm bones (HP:0003956) | 2.26496097 |
| 66 | Bowing of the arm (HP:0006488) | 2.26496097 |
| 67 | Bone pain (HP:0002653) | 2.22583171 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.22253373 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.19791768 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.19791768 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.19572965 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.14869409 |
| 73 | Alacrima (HP:0000522) | 2.13461338 |
| 74 | Flat acetabular roof (HP:0003180) | 2.12767108 |
| 75 | Hyperacusis (HP:0010780) | 2.12427983 |
| 76 | Protrusio acetabuli (HP:0003179) | 2.11437710 |
| 77 | Thoracic kyphosis (HP:0002942) | 2.08679613 |
| 78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.07753636 |
| 79 | Abnormality of the lumbar spine (HP:0100712) | 2.07669619 |
| 80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05279648 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04754655 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.04754655 |
| 83 | Genu recurvatum (HP:0002816) | 2.03267145 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.02625014 |
| 85 | Renal duplication (HP:0000075) | 2.01525539 |
| 86 | Congenital glaucoma (HP:0001087) | 2.01036863 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00810142 |
| 88 | Pathologic fracture (HP:0002756) | 1.99503353 |
| 89 | Pustule (HP:0200039) | 1.99141587 |
| 90 | Bronchomalacia (HP:0002780) | 1.98385652 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 1.97951179 |
| 92 | Hand muscle atrophy (HP:0009130) | 1.97108866 |
| 93 | Narrow nasal bridge (HP:0000446) | 1.95094046 |
| 94 | Dementia (HP:0000726) | 1.94545181 |
| 95 | Atrophic scars (HP:0001075) | 1.94267720 |
| 96 | Personality changes (HP:0000751) | 1.92431901 |
| 97 | Upper motor neuron abnormality (HP:0002127) | 1.91891084 |
| 98 | Gingivitis (HP:0000230) | 1.91586952 |
| 99 | Insomnia (HP:0100785) | 1.90959144 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90920822 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90920822 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90920822 |
| 103 | Choanal stenosis (HP:0000452) | 1.90521265 |
| 104 | Rectovaginal fistula (HP:0000143) | 1.89552154 |
| 105 | Rectal fistula (HP:0100590) | 1.89552154 |
| 106 | Pointed chin (HP:0000307) | 1.89178825 |
| 107 | Short chin (HP:0000331) | 1.88595251 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.87899461 |
| 109 | Vasculitis (HP:0002633) | 1.86705346 |
| 110 | Focal seizures (HP:0007359) | 1.85793207 |
| 111 | Broad thumb (HP:0011304) | 1.85184648 |
| 112 | Progressive neurologic deterioration (HP:0002344) | 1.83736227 |
| 113 | Visual hallucinations (HP:0002367) | 1.83323324 |
| 114 | Orthostatic hypotension (HP:0001278) | 1.83144166 |
| 115 | Progressive sensorineural hearing impairment (HP:0000408) | 1.81908743 |
| 116 | Shawl scrotum (HP:0000049) | 1.81776273 |
| 117 | Pulmonary infiltrates (HP:0002113) | 1.81313017 |
| 118 | Abnormality of oral frenula (HP:0000190) | 1.80873024 |
| 119 | Hyperextensible skin (HP:0000974) | 1.80870284 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80412269 |
| 121 | Protuberant abdomen (HP:0001538) | 1.80347538 |
| 122 | Nephritis (HP:0000123) | 1.80090377 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.79707771 |
| 124 | Petechiae (HP:0000967) | 1.79063980 |
| 125 | Cervical subluxation (HP:0003308) | 1.77611729 |
| 126 | Xanthomatosis (HP:0000991) | 1.77245810 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 1.76833184 |
| 128 | Inappropriate behavior (HP:0000719) | 1.76174633 |
| 129 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76164974 |
| 130 | Vertebral fusion (HP:0002948) | 1.75879443 |
| 131 | Peripheral demyelination (HP:0011096) | 1.74712887 |
| 132 | Nausea (HP:0002018) | 1.74068736 |
| 133 | Premature loss of primary teeth (HP:0006323) | 1.73246421 |
| 134 | Clumsiness (HP:0002312) | 1.73210409 |
| 135 | Abnormality of the thoracic spine (HP:0100711) | 1.72405757 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.71605194 |
| 137 | Selective tooth agenesis (HP:0001592) | 1.71066514 |
| 138 | Emphysema (HP:0002097) | 1.70652523 |
| 139 | Vaginal fistula (HP:0004320) | 1.70419555 |
| 140 | Esophageal varix (HP:0002040) | 1.69945564 |
| 141 | Atonic seizures (HP:0010819) | 1.68873883 |
| 142 | Bladder diverticulum (HP:0000015) | 1.68743145 |
| 143 | Achilles tendon contracture (HP:0001771) | 1.68605030 |
| 144 | Hematochezia (HP:0002573) | 1.68268496 |
| 145 | Hamartoma (HP:0010566) | 1.67661987 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.67440052 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.67024585 |
| 148 | Muscle fibrillation (HP:0010546) | 1.66361965 |
| 149 | Intestinal fistula (HP:0100819) | 1.66123474 |
| 150 | Cupped ribs (HP:0000887) | 1.66059596 |
| 151 | Thick nail (HP:0001805) | 1.65987784 |
| 152 | Gangrene (HP:0100758) | 1.65410784 |
| 153 | Keratoconjunctivitis (HP:0001096) | 1.64815803 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.64546396 |
| 155 | Tongue fasciculations (HP:0001308) | 1.64314185 |
| 156 | Anteriorly placed anus (HP:0001545) | 1.64044580 |
| 157 | Milia (HP:0001056) | 1.63803786 |
| 158 | Hypophosphatemia (HP:0002148) | 1.63358165 |
| 159 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62374223 |
| 160 | Fragile skin (HP:0001030) | 1.62306993 |
| 161 | Macroorchidism (HP:0000053) | 1.61624352 |
| 162 | Elevated alkaline phosphatase (HP:0003155) | 1.61614597 |
| 163 | Chronic obstructive pulmonary disease (HP:0006510) | 1.60917489 |
| 164 | Obstructive lung disease (HP:0006536) | 1.60917489 |
| 165 | Focal motor seizures (HP:0011153) | 1.60882947 |
| 166 | Acrocyanosis (HP:0001063) | 1.60627852 |
| 167 | Spinal muscular atrophy (HP:0007269) | 1.60158039 |
| 168 | Flared iliac wings (HP:0002869) | 1.59385297 |
| 169 | Aneurysm (HP:0002617) | 1.59169874 |
| 170 | Restrictive lung disease (HP:0002091) | 1.59140515 |
| 171 | Action tremor (HP:0002345) | 1.58861921 |
| 172 | Short 1st metacarpal (HP:0010034) | 1.58171909 |
| 173 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.58171909 |
| 174 | Split hand (HP:0001171) | 1.57722638 |
| 175 | Megalencephaly (HP:0001355) | 1.57332855 |
| 176 | Elfin facies (HP:0004428) | 1.56450085 |
| 177 | Deviation of the hallux (HP:0010051) | 1.56339134 |
| 178 | Abnormality of the gastric mucosa (HP:0004295) | 1.54614397 |
| 179 | Abnormality of the periventricular white matter (HP:0002518) | 1.53271807 |
| 180 | Heterotopia (HP:0002282) | 1.52741112 |
| 181 | Abnormality of the labia minora (HP:0012880) | 1.52622498 |
| 182 | Poikiloderma (HP:0001029) | 1.52305460 |
| 183 | Hallux valgus (HP:0001822) | 1.51279123 |
| 184 | Ankle contracture (HP:0006466) | 1.50283166 |
| 185 | Deep palmar crease (HP:0006191) | 1.49262007 |
| 186 | Supranuclear gaze palsy (HP:0000605) | 1.48986757 |
| 187 | Growth hormone excess (HP:0000845) | 1.48985817 |
| 188 | Neoplasm of the heart (HP:0100544) | 1.48965328 |
| 189 | Bowel diverticulosis (HP:0005222) | 1.48933560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 6.24539927 |
| 2 | ICK | 4.89226391 |
| 3 | NME2 | 3.42546138 |
| 4 | MAP3K9 | 3.20730367 |
| 5 | BMX | 2.84635344 |
| 6 | MAP3K14 | 2.79513924 |
| 7 | LATS2 | 2.64357741 |
| 8 | TRIB3 | 2.52863340 |
| 9 | MAP3K6 | 2.44635116 |
| 10 | RIPK1 | 2.42985930 |
| 11 | MAPK15 | 2.42817256 |
| 12 | TBK1 | 2.19800191 |
| 13 | GRK7 | 2.15808820 |
| 14 | EPHA4 | 2.07868495 |
| 15 | PRKD3 | 2.06525794 |
| 16 | DAPK1 | 2.05399554 |
| 17 | EPHA2 | 2.03946540 |
| 18 | RIPK4 | 2.01334873 |
| 19 | UHMK1 | 1.94884113 |
| 20 | PAK6 | 1.92842722 |
| 21 | MAP3K11 | 1.92275327 |
| 22 | FGFR4 | 1.89942709 |
| 23 | IRAK4 | 1.88922381 |
| 24 | KSR2 | 1.76248168 |
| 25 | NTRK3 | 1.75338140 |
| 26 | MAP3K3 | 1.65758760 |
| 27 | TYK2 | 1.63312315 |
| 28 | PRKD2 | 1.61678536 |
| 29 | MST1R | 1.60880759 |
| 30 | DYRK1B | 1.52949950 |
| 31 | BLK | 1.47576141 |
| 32 | IKBKB | 1.46516314 |
| 33 | NTRK1 | 1.41320456 |
| 34 | MAP4K1 | 1.40272285 |
| 35 | MARK1 | 1.39957924 |
| 36 | PINK1 | 1.37316200 |
| 37 | PTK2 | 1.34440906 |
| 38 | TGFBR2 | 1.31513112 |
| 39 | MAP3K13 | 1.28894234 |
| 40 | CHUK | 1.28814569 |
| 41 | NTRK2 | 1.28079685 |
| 42 | STK38 | 1.27230070 |
| 43 | IKBKE | 1.26913778 |
| 44 | DAPK2 | 1.26912037 |
| 45 | MOS | 1.22869869 |
| 46 | IRAK2 | 1.22782414 |
| 47 | ALK | 1.21890710 |
| 48 | TAOK1 | 1.21679615 |
| 49 | FER | 1.17355120 |
| 50 | MINK1 | 1.16950517 |
| 51 | MAP2K3 | 1.16397946 |
| 52 | ARAF | 1.15145884 |
| 53 | PHKG2 | 1.14174111 |
| 54 | PHKG1 | 1.14174111 |
| 55 | * PDGFRA | 1.13580080 |
| 56 | PKN2 | 1.12605752 |
| 57 | MAP3K1 | 1.12588593 |
| 58 | MAP3K10 | 1.12525951 |
| 59 | KSR1 | 1.12222493 |
| 60 | EPHB2 | 1.11119367 |
| 61 | CDK12 | 1.08775585 |
| 62 | SMG1 | 1.07789905 |
| 63 | PTK6 | 1.05510687 |
| 64 | SIK2 | 1.04536759 |
| 65 | CAMKK1 | 1.03414251 |
| 66 | LMTK2 | 1.01656531 |
| 67 | PRPF4B | 1.00998081 |
| 68 | CSF1R | 0.99364321 |
| 69 | JAK3 | 0.98222908 |
| 70 | ABL2 | 0.95964426 |
| 71 | CDK6 | 0.95064787 |
| 72 | MAP3K2 | 0.94753243 |
| 73 | PAK4 | 0.92883709 |
| 74 | LATS1 | 0.92805304 |
| 75 | MTOR | 0.92376230 |
| 76 | DMPK | 0.92300290 |
| 77 | CAMK1D | 0.87775677 |
| 78 | SIK3 | 0.87671471 |
| 79 | * CDC42BPA | 0.87500404 |
| 80 | JAK1 | 0.87242664 |
| 81 | * TYRO3 | 0.86834044 |
| 82 | EPHB1 | 0.85663123 |
| 83 | AKT3 | 0.85053492 |
| 84 | PAK2 | 0.84249629 |
| 85 | IRAK1 | 0.83899610 |
| 86 | PAK3 | 0.82169951 |
| 87 | PIM2 | 0.82101277 |
| 88 | GSK3A | 0.81729027 |
| 89 | TTN | 0.81180200 |
| 90 | BMPR2 | 0.80013962 |
| 91 | NEK1 | 0.79736696 |
| 92 | TAOK2 | 0.76409254 |
| 93 | MAP3K4 | 0.76343704 |
| 94 | ZAP70 | 0.76176860 |
| 95 | FGFR3 | 0.72730928 |
| 96 | TESK2 | 0.71932377 |
| 97 | * CSK | 0.71907463 |
| 98 | * CDK5 | 0.71567307 |
| 99 | YES1 | 0.69649454 |
| 100 | RAF1 | 0.69278436 |
| 101 | NEK9 | 0.68880309 |
| 102 | ACVR1B | 0.68838879 |
| 103 | FGFR1 | 0.68601408 |
| 104 | SCYL2 | 0.68174344 |
| 105 | RPS6KA2 | 0.67994312 |
| 106 | RET | 0.67587122 |
| 107 | PDPK1 | 0.64790906 |
| 108 | MAP3K5 | 0.63297188 |
| 109 | TRPM7 | 0.62887247 |
| 110 | RPS6KA1 | 0.60513817 |
| 111 | STK24 | 0.60445996 |
| 112 | CAMK2B | 0.60263011 |
| 113 | EEF2K | 0.60122244 |
| 114 | RPS6KL1 | 0.59935959 |
| 115 | RPS6KC1 | 0.59935959 |
| 116 | CDK7 | 0.57682302 |
| 117 | ERN1 | 0.57458067 |
| 118 | ERBB3 | 0.56642352 |
| 119 | PRKCZ | 0.55274174 |
| 120 | MAP2K1 | 0.53568356 |
| 121 | EGFR | 0.52854971 |
| 122 | DAPK3 | 0.52661477 |
| 123 | MARK2 | 0.52513463 |
| 124 | MAP2K2 | 0.52331250 |
| 125 | ERBB2 | 0.51531450 |
| 126 | SGK1 | 0.51263213 |
| 127 | MET | 0.50164647 |
| 128 | ADRBK2 | 0.49186058 |
| 129 | STK11 | 0.47149596 |
| 130 | MAPK10 | 0.46831371 |
| 131 | RPS6KA6 | 0.46668282 |
| 132 | JAK2 | 0.46197335 |
| 133 | TESK1 | 0.45376397 |
| 134 | PRKG2 | 0.45115246 |
| 135 | PRKAA1 | 0.44794825 |
| 136 | CAMK2A | 0.44307262 |
| 137 | * FGR | 0.42601095 |
| 138 | EPHA3 | 0.42099071 |
| 139 | HIPK2 | 0.41569810 |
| 140 | CAMK2G | 0.41149127 |
| 141 | PRKCI | 0.40952366 |
| 142 | MAP2K6 | 0.40750295 |
| 143 | MAPK4 | 0.40203950 |
| 144 | PRKD1 | 0.39243777 |
| 145 | SIK1 | 0.39176762 |
| 146 | * LYN | 0.37864241 |
| 147 | * RPS6KA3 | 0.37670259 |
| 148 | PRKCH | 0.37178959 |
| 149 | SYK | 0.35989670 |
| 150 | DYRK3 | 0.35605508 |
| 151 | MAPK11 | 0.35236414 |
| 152 | CAMK1G | 0.35099296 |
| 153 | AKT2 | 0.34567847 |
| 154 | PDK1 | 0.34040365 |
| 155 | * SRC | 0.33641062 |
| 156 | MAP3K8 | 0.32081613 |
| 157 | BRAF | 0.27833333 |
| 158 | HCK | 0.25405797 |
| 159 | MAPKAPK2 | 0.25198092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.25553814 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.65494792 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64149514 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.61241186 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32458330 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30075124 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.29528258 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22071336 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.21297436 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19014284 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18523531 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.03173249 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.01176236 |
| 14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.99470007 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.95706933 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89693650 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.88687475 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86789879 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.85033535 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.82768610 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77543502 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.72261720 |
| 23 | * Tuberculosis_Homo sapiens_hsa05152 | 1.71393165 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70024224 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.68659798 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65568638 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63959812 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63338689 |
| 29 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.62795984 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60138277 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.59732996 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59429597 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55445820 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54469987 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46072635 |
| 36 | * Adherens junction_Homo sapiens_hsa04520 | 1.43059044 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.42760760 |
| 38 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.39230761 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.37262247 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.36328485 |
| 41 | * Gap junction_Homo sapiens_hsa04540 | 1.35416141 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.32722431 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.32665085 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31723981 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31707302 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31676679 |
| 47 | * Tight junction_Homo sapiens_hsa04530 | 1.31147291 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28705147 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.27478586 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26639868 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.26213851 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.24023600 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.23678589 |
| 54 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.23310021 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.22970196 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22504335 |
| 57 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20982269 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20205540 |
| 59 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.19522413 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19094286 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.18815777 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 1.17781438 |
| 63 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17202943 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.16414087 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14603122 |
| 66 | * Bladder cancer_Homo sapiens_hsa05219 | 1.14472417 |
| 67 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14310248 |
| 68 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13691040 |
| 69 | * Focal adhesion_Homo sapiens_hsa04510 | 1.13525437 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12319385 |
| 71 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10660772 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 1.10056634 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10013230 |
| 74 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.09563226 |
| 75 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.08895347 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 1.08371989 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.08115432 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07762477 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07725609 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07690110 |
| 81 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06912516 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06722155 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 1.04986724 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 1.03785775 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03455881 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02554221 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02247424 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01846437 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01081922 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.00189872 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99977975 |
| 92 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99720704 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99617889 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99122850 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97332199 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.96972623 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95342863 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95133258 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.95002336 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94357719 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94153168 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93930915 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93561288 |
| 104 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93501013 |
| 105 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93257730 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92969526 |
| 107 | Morphine addiction_Homo sapiens_hsa05032 | 0.91943531 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91613870 |
| 109 | * Hepatitis B_Homo sapiens_hsa05161 | 0.90857869 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90040748 |
| 111 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86884910 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85496925 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85001438 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84774448 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84666483 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84577817 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.83005640 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82737377 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82628526 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82264799 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81000633 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78928004 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.78219461 |
| 124 | * Endocytosis_Homo sapiens_hsa04144 | 0.77205020 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76596800 |
| 126 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75476433 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.75410731 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75182924 |
| 129 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74307976 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73879229 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73104461 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72453642 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72194252 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72085094 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72009501 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71120131 |
| 137 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70550159 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69918034 |
| 139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69715502 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65825734 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65330263 |
| 142 | Melanoma_Homo sapiens_hsa05218 | 0.65235448 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64851281 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64369842 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63271808 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62689327 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.62116087 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61164110 |
| 149 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60967873 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59673699 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59657913 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58463108 |
| 153 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58102509 |
| 154 | * Shigellosis_Homo sapiens_hsa05131 | 0.58004736 |
| 155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57694993 |
| 156 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57203059 |
| 157 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56635368 |
| 158 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55411002 |
| 159 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51572223 |
| 160 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48004256 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.45718800 |
| 162 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43176147 |
| 163 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41751682 |
| 164 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40271038 |
| 165 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37784843 |
| 166 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35585334 |
| 167 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35324369 |
| 168 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34221267 |
| 169 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33831182 |
| 170 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27756986 |

